- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Other Neoplasms Solid Tumors in United Kingdom
Total 9788 results
-
National Cancer Institute (NCI)RecruitingSolid Tumor | Refractory Solid Tumors | Malignant Solid Tumors | Other Neoplasms Solid Tumors | Pediatric Solid TumorUnited States
-
Laminar PharmaceuticalsRoyal Marsden NHS Foundation Trust; Vall d'Hebron Institute of Oncology; Specialized... and other collaboratorsCompletedGlioma | Other Solid TumoursSpain, United Kingdom
-
AstraZenecaCompletedAdvanced Solid Metastatic TumorUnited Kingdom
-
Astellas Pharma Global Development, Inc.Seagen Inc.CompletedMetastatic Urothelial Cancer and Other Malignant Solid TumorsUnited States, Canada
-
Mateon TherapeuticsCancer Research UKCompleted
-
Chugai Pharma Europe Ltd.CompletedSolid TumorsUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingSolid Tumor | Metastatic Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Solid Carcinoma | Metastatic TumorUnited States
-
Immatics US, Inc.CompletedCancer | Solid Tumor | Refractory Solid Tumors | Recurrent Solid TumorsUnited States, Germany
-
Eisai LimitedCompleted
-
AstraZenecaCompletedRefractory Solid Tumors | Cancer TumorUnited States
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedMalignant Solid TumorsUnited Kingdom
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedCancer, Advanced Solid TumorsUnited Kingdom
-
Eli Lilly and CompanyCompletedSolid Tumor | Malignant Solid Tumor | Metastatic TumorGermany, United States, France
-
PharmaMarCompletedMajor Advanced Solid Tumors Other Than ColorectalUnited States
-
PharmaMarCompletedAdvanced Solid TumorsUnited Kingdom, Switzerland
-
Queen Mary University of LondonRecruiting
-
AstraZenecaActive, not recruitingSolid TumorsUnited Kingdom, Canada
-
PharmaMarCompletedSpecific Advanced Solid TumorsSpain, United Kingdom
-
Leucid BioRecruitingTumor, SolidUnited Kingdom
-
Georgetown UniversityImmune System Key LtdRecruitingSolid Tumor | KRAS Mutation-Related TumorsUnited States
-
AstraZenecaCompletedSolid TumorsUnited States, France, United Kingdom
-
Nerviano Medical SciencesTerminatedAdvanced/Metastatic Solid TumorsUnited Kingdom, France
-
LondonPharma Ltd.UnknownSolid TumoursUnited Kingdom
-
Eisai Inc.Completed
-
AstraZenecaTerminated
-
Hoffmann-La RocheCompleted
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
Alligator Bioscience ABCompleted
-
Hoffmann-La RocheCompletedSolid TumorUnited Kingdom, Netherlands
-
Athenex, Inc.CompletedSolid TumorUnited States, United Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Netherlands, United States, United Kingdom
-
Cancer Research UKTerminatedAdvanced Solid TumoursUnited Kingdom
-
Keystone Nano, IncNational Cancer Institute (NCI); National Institutes of Health (NIH)UnknownCarcinoma | Cancer | Solid Tumors | TumorUnited States
-
OSI PharmaceuticalsCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
GlaxoSmithKlineCompletedSolid Tumor CancerUnited Kingdom
-
Novartis PharmaceuticalsCompletedSolid TumorsNetherlands, Spain, United Kingdom, United States, Belgium
-
AstraZenecaParexelTerminatedAdvanced Solid TumoursUnited Kingdom, United States
-
Chroma TherapeuticsCompletedSafety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid TumoursSolid TumorNetherlands, United Kingdom
-
Ikena OncologyRecruitingSolid Tumor | Solid Tumors, Adult | Malignant Pleural Mesothelioma (MPM) | Epithelioid Hemangioendothelioma (EHE) | NF2 Deficient Mesothelioma | Other NF2 Deficient Solid Tumors and Solid Tumors With YAP1/TAZ Fusion Genes | NF2 Deficiency | YAP1 or TAZ Gene FusionsUnited States, United Kingdom
-
Stemline Therapeutics, Inc.CompletedStudy of the PI3K Inhibitor SL-901 in Patients With Advanced Solid Tumors With Advanced Solid TumorsAdvanced Solid TumorUnited Kingdom
-
Turning Point Therapeutics, Inc.TerminatedAdvanced Solid Tumor | Metastatic Solid Tumor | KRAS Mutation-Related TumorsUnited States
-
Heidelberg Pharma AGTerminatedAdvanced Solid TumoursUnited Kingdom
-
Mina Alpha LimitedActive, not recruitingSolid Tumor, AdultUnited Kingdom
-
CephalonCompletedSolid TumorFrance, United Kingdom
-
Leap Therapeutics, Inc.Cancer Research Institute, New York CityCompletedUnresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMelanoma | Solid Tumor | Metastatic Melanoma | NeoplasmUnited States, United Kingdom
-
GlaxoSmithKlineCompletedSolid TumoursUnited States, United Kingdom
-
Hoffmann-La RocheTerminatedSolid TumorsBelgium, United States, Australia, Denmark, Spain, United Kingdom
-
MapKure, LLCRecruitingSolid Tumor | B-Raf Mutation-Related TumorsUnited States, Australia
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Sweden, Netherlands, United States, United Kingdom